Data Integrity: Production Environment

Size: px
Start display at page:

Download "Data Integrity: Production Environment"

Transcription

1 Data Integrity: Production Environment MANUAL AND AUTOMATED SYSTEMS Ciara Turley GMP Conference 12 th November 2014

2 Content GMP Guide requirements and application to processing equipment Security Audit trail Accuracy checks Storage of data Print outs Vendors URS and qualification Periodic evaluation Deficiencies cited 12th November

3 Security Management systems for data and for documents should be designed to record the identity of operators entering, changing, confirming or deleting data, including date and time. User access individual passwords Segregation of duties Overlap of duties risk assessed. 12th November

4 Audit trail Consideration should be given, based on a risk assessment, to building into the system the creation of a record of all GMP-relevant changes and deletions. For change or deletion of GMP relevant data the reason should be documented. Audit trails need to be available and convertible to an intelligible form and regularly reviewed Self Inspection. Incidents related to computerized systems that could affect the quality of intermediates or APIs or the reliability of records or test results should be recorded and investigated. 12th November

5 Data accuracy checks For critical data entered manually, there should be an additional check on the accuracy of the data. This check may be done by a second operator or by validated electronic means. The criticality and the potential consequences of erroneous or incorrectly entered data to a system should be covered by risk management. If data are transferred to another data format or system, validation should include checks that data are not altered in value and/or meaning during this migration process. 12th November

6 Storage of data Data should be secured by both physical and electronic means against damage. Access to data should be ensured throughout the retention period. Regular back-ups of all relevant data should be done. Integrity and accuracy of backup data and the ability to restore the data should be checked during validation and monitored periodically. 12th November

7 Print outs It should be possible to obtain clear printed copies of electronically stored data. Can the information be securely transferred or downloaded to storage media in an intelligible format and then reviewed / inspected? For records supporting batch release it should be possible to generate printouts indicating if any of the data has been changed since the original entry. 12th November

8 Vendors Competence and reliability of supplier assessed and documented. Agreements with suppliers for installation, qualification, maintenance, back up, administration access. 12th November

9 URS and qualification User Requirement Specifications should describe the required functions of the computerised system and be based on documented risk assessment and GMP impact. Evidence of appropriate test methods and test scenarios should be demonstrated. Particularly, system (process) parameter limits, data limits and error handling should be considered. 12th November

10 Periodic evaluations Computerised systems should be periodically evaluated to confirm that they remain in a valid state and are compliant with GMP. Such evaluations should include, where appropriate, the current range of functionality, deviation records, incidents, problems, upgrade history, performance, reliability, security and validation status reports. 12th November

11 Points to note: Understand the capability of your equipment, know if it stores electronic data, assess if parameters are changed what impact it will have. Computer programming can potentially replace human judgment. Annex 11 provides guidance to help ensure electronic record integrity, which in turn helps ensure product safety. Directive 2003/94/EC, 91/412/EEC Article 5: The manufacturer shall regularly review his manufacturing methods in the light of scientific and technical progress 12th November

12 Examples of Deficiencies The following deficiencies were noted with regards to the blister packaging machine There was no controlled recipe in place to confirm that parameter settings on the machine were those approved. The time on the HMI was incorrect the actual time (taken from the wall clock in the packaging area was recorded at 12:15, the machine time was displayed as 11:08. A generic operator password was in use Audit trails were not reviewed. The print out function was not enabled and there was no assessment to determine if stored data could be securely transferred or downloaded to storage media in an intelligible format for review Manufacturing data since 2003 from a previous manufacturer / owner was retained on machine. 12th November

13 Examples of Deficiencies The qualification and data integrity controls for the filling machine were considered inadequate in that: There was no technical agreement with the vendor A single generic user name and password was used to access and operate the equipment. The time setting on the software control was inaccurate. The audit trail could not be generated at the time of inspection. The system and security for archiving of data was not known The User Requirement Specification did not specifically state all the requirements for the machine and was not linked to any critical process parameters / variables 12th November

14 Examples of Deficiencies The company is advised that manufacturing controls should be updated in line with technical progress (ref. Directive 2003/94/EC, Article 5 (2)). In particular fluid bed dryers should be equipped with chart recorders to facilitate monitoring and recording of the granulate drying process. The qualification / revalidation was deficient in that there was no consideration of the impact of updated requirements since the initial IOQ, specifically Annex th November

15 References EU Guidelines to GMP EMA Questions and Answers: Good manufacturing practice 12th November

COMPUTERISED SYSTEMS

COMPUTERISED SYSTEMS ANNEX 11 COMPUTERISED SYSTEMS PRINCIPLE This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

Computer System Validation Perform a Gap Analysis of your CSV Processes

Computer System Validation Perform a Gap Analysis of your CSV Processes Computer System Validation Perform a Gap Analysis of your CSV Processes Chris Wubbolt, QACV Consulting Computer and Software Validation Conference April 27, 2017 www.qacvconsulting.com 1 Objectives Computer

More information

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0) Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a

More information

Computerised System Validation

Computerised System Validation Computerised System Validation Considerations for the Validation Lifecycle Paul Moody GMP Conference 12 th November 2014 Regulatory References EU GMP Annex 11 (2011) http://ec.europa.eu/health/files/eudralex/vol-4/annex11_01-2011_en.pdf

More information

EU Annex 11 update. An ISPE interpretation

EU Annex 11 update. An ISPE interpretation EU Annex 11 update An ISPE interpretation ISPE Interpretation Published by Winnie Cappucci Chris Clark Tim Goossens Sion Wyn Disclaimer ISPE cannot ensure and does not warrant that computerized systems

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 08 April 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Computerised Systems Inspection Expectations ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Paul Moody, Inspector Slide 1 Presentation Contents Brief Introduction to the IMB Regulatory References

More information

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:

More information

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008)

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) Principle The introduction of computerised systems into systems of manufacturing, including storage,

More information

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY TO and

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY  TO and 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org 31 October 2008 Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY EMAIL TO entr-gmp@ec.europa.eu

More information

Data Integrity Why is it important? DADM Conference - 22 August 2017

Data Integrity Why is it important? DADM Conference - 22 August 2017 Data Integrity Why is it important? DADM Conference - 22 August 2017 Maibritt Haugaard Møller, System Validation Expert Mette Ravn, Vice President, Data Management, IT and System Validation Overview of

More information

Ensure Data Integrity Compliance Enterprise-Wide

Ensure Data Integrity Compliance Enterprise-Wide Ensure Data Integrity Compliance Enterprise-Wide PharmaQual 360 º Conference February 24, 2017 Chris Wubbolt QACV Consulting, LLC www.qacvconsulting.com 1 Objectives What is data integrity and the definition

More information

Electronic Systems - Regulators Observations

Electronic Systems - Regulators Observations Electronic Systems - Regulators Observations Catherine Neary QP Forum Trinity College Dublin, 16 th April 2015 Agenda Introduction to Topic Data Integrity Considerations for any Electronic System Summary

More information

Oracle Tech Cloud GxP Position Paper December, 2016

Oracle Tech Cloud GxP Position Paper December, 2016 Oracle Tech Cloud GxP Position Paper Page 1 of 29 Oracle Tech Cloud GxP Position Paper December, 2016 Prepared By: Subbu Viswanathan, Head of Solutions Reviewed By: David Blewitt, VP Cloud Compliance Oracle

More information

Summary of Significant Changes. Policy

Summary of Significant Changes. Policy This Policy replaces POL251/1 Copy Number Effective 03/04/17 Summary of Significant Changes Addition of requirements of 2016 review of Guidance by MHRA, ALCOA+, and documents related to Policy The purpose

More information

Validation of MES and Manufacturing Automation systems

Validation of MES and Manufacturing Automation systems Validation of MES and Manufacturing Automation systems The FDA Group Presentation APRIL 26, 2017 Chinmoy Roy, B.S. (Hons.) MSCS Industry Consultant 1 Agenda What is a MES Validation concepts Validation

More information

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND

More information

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 SIEMENS AG Industry Sector VSS Pharma D-76187 Karlsruhe, Germany E-Mail: pharma@siemens.com March 2015 A5E35829023-AA

More information

PTC s Windchill Product Lifecycle Management (PLM) System Facilitates Part 11 / Annex 11 Compliance

PTC s Windchill Product Lifecycle Management (PLM) System Facilitates Part 11 / Annex 11 Compliance PTC s Product Lifecycle Management (PLM) ystem Facilitates Part 11 / Annex 11 Compliance A White Paper by: Diane Gleinser, r. VP olutions and ervices, UDM Life ciences Michael Prudhomme, olution Director,

More information

LEGAL REQUIREMENTS and DATA INTEGRITY...

LEGAL REQUIREMENTS and DATA INTEGRITY... LEGAL REQUIREMENTS and DATA INTEGRITY... 1 1 DI Guidances MHRA GMP DI Definitions & Guidance for Industry, March 2015 Guidance on Good Data & Record Management, March, 2016 Data Integrity and Compliance

More information

Data Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0)

Data Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0) Data Integrity Through the Life Cycle Balancing Quality and Innovation Sion Wyn Conformity +44 (0) 1492 642622 sion.wyn@conform-it.com Theme Achieving harmony Balancing quality, safety, and compliance

More information

Computerized Systems Validation. Gai Anbar, CEO March 2013

Computerized Systems Validation. Gai Anbar, CEO March 2013 Computerized Systems Validation Gai Anbar, CEO March 2013 About Comply Comply provides consulting services in the area of Computerized Systems Validation and IT QA as well as development and implementation

More information

The EDQM Inspection Programme

The EDQM Inspection Programme The EDQM Inspection Programme Prague, 20 September 2017 Dr Sotirios Paraschos, Inspector Certification of Substances Department, EDQM Overview: EDQM Inspection Programme in the frame of Certification Procedure

More information

Develop a Roadmap for the Implementation of a Global CSV Program. Eileen Cortes April 26, 2017

Develop a Roadmap for the Implementation of a Global CSV Program. Eileen Cortes April 26, 2017 Develop a Roadmap for the Implementation of a Global CSV Program Eileen Cortes April 26, 2017 Agenda CSV Regulation Principles CSV Lifecycle Approach CSV and Quality Management Governance Program and CSV

More information

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2 Introduction 1 The Requirements in Short 2 SIMATIC IT Meeting the Requirements with SIMATIC IT R&D Suite V7.1 3 SIMATIC IT R&D SUITE V7.1 Evaluation List for SIMATIC IT R&D Suite V7.1 4 Product Information

More information

Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation

Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Datasheet Introduction US Part 11 in Title 21 of Code

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Introduction to Medicines Inspections Technical Updates:

Introduction to Medicines Inspections Technical Updates: Introduction to Medicines Inspections Technical Updates: GMP inspections of Active Pharmaceutical Ingrédients and Finished Pharmaceutical Products (including Reproductive Health Products) Vimal Sachdeva,

More information

Contents. Contents (13) 1 Qualification (21)

Contents. Contents (13) 1 Qualification (21) 1 Qualification (21) 1.A Official requirements (23) 1.A.1 Legal aspects of qualification (23) 1.A.2 Documentation of the qualification (26) 1.A.3 Design Qualification (DQ) (27) 1.A.4 Installation Qualification

More information

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it.

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it. 1 How to Meet New MHRA, FDA, EMA and WHO Data Integrity Guidelines white paper New Data Integrity Regulations and Practical Advice for Life Science Laboratories we prove it. 2 How to Avoid Poor Temperature

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

Current Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective

Current Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective Current Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective Mark Birse / Richard Andrews, MHRA Data Integrity has no relationship with product

More information

[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES

[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES A Basic Overview: Meeting the PIC/S Requirements for a Computerized System Lynn Archambault Waters Corporation, Milford, MA, USA INTRODUCTION The Pharmaceutical Inspection Convention and Pharmaceutical

More information

Lessons from Pharmaceutical Laboratory related FDA Warning Letters

Lessons from Pharmaceutical Laboratory related FDA Warning Letters Lessons from Pharmaceutical Laboratory related FDA Warning Letters The Agilent Critical Compliance Seminar 2016 Ludwig Huber Ludwig_huber@labcompliance.com Overview FDA Inspections and reports GMP compliance

More information

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY

GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 GUIDANCE NOTE 37 MEDICAL GASES DATA INTEGRITY 2017 Copyright 2017 by British Compressed Gases Association. First printed 2017. All rights reserved. No

More information

Good Documentation Practices. Documentation Requirements For Regulated Environments

Good Documentation Practices. Documentation Requirements For Regulated Environments Good Documentation Practices Documentation Requirements For Regulated Environments Agenda Example Deficiency 2014 Result Of Poor Record Creation Data Integrity EU GMP Chapter 4 Requirements Non GMP Compliant

More information

Deficiencies found in Inspections and QP Responsibilities

Deficiencies found in Inspections and QP Responsibilities Deficiencies found in Inspections and QP Responsibilities Ciara Turley, HPRA Inspector QP Forum, Trinity College, Dublin 25 th April 2017 Dublin Key QP Responsibilities Chapter 1, 1.4 (xv) Medicinal products

More information

COMPUTERIZED SYSTEM VALIDATION

COMPUTERIZED SYSTEM VALIDATION www.kevintech.com Current Practices of COMPUTERIZED SYSTEM VALIDATION Kevin ISSUE.1/2017 CONNECT INSIDE - Basics of Computerized System Validation - Life Cycle of Computerized System The less manual the

More information

GAMP Guideline & Validation Documentation

GAMP Guideline & Validation Documentation GAMP Guideline & Validation Documentation Danilo Maruccia Milano, 21 Marzo 2006 GAMP Guideline & Validation Documentation GAMP Guideline Planning documents Specification Documents Testing Documents Acceptance

More information

Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0

Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0 Compliance Response Electronic Records / Electronic Signatures for COMOS V10.0 SIEMENS AG Industry Sector I IA VSS Pharma D-76187 Karlsruhe, Germany E-mail: pharma@siemens.com November 2013 SIEMENS AG

More information

Common deficiencies/ hot topics

Common deficiencies/ hot topics Common deficiencies/ hot topics Non-sterile & API manufacture Oisín Daly GMP Conference 7 February 2017 Dublin Non-sterile finished product manufacture Deficiencies by Eudralex Vol. 4 GMP guide > 60% 3

More information

Most Common Deficiencies Found. Dr Florence Benoit-Guyod Head of the inspection section Certification of Substances Department

Most Common Deficiencies Found. Dr Florence Benoit-Guyod Head of the inspection section Certification of Substances Department Most Common Deficiencies Found by EDQM Dr Florence Benoit-Guyod Head of the inspection section Certification of Substances Department Overview Fact & Figures Main deficiencies Conclusion 2 Inspection figures

More information

The ultimate specification for Audit Trails A simple guideline for the so called Audit Trail Review

The ultimate specification for Audit Trails A simple guideline for the so called Audit Trail Review The ultimate specification for Audit Trails A simple guideline for the so called Audit Trail Review What is exactly a GMP Audit Trail purpose, objective, types and implementation? What is an Audit Trail

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Calyx Chemicals & Pharmaceuticals Ltd Unit:

More information

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide. Computerised Systems Wholesale Distribution Information Day, Alfred Hunt Inspector Date Insert on Master Slide Slide 1 Index What is a computerised system Updates to EU GDPs Expectations Case studies Slide

More information

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it.

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 1 How to Meet New MHRA, FDA and WHO Data Integrity Guidelines WHITE PAPER Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 2 How to

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev05MAR15

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev05MAR15 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Regulatory Expectations, Standards & Guidelines

Regulatory Expectations, Standards & Guidelines Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory

More information

OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use

OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use OECD Working Group on Good Laboratory Practice Template for submission of comments on draft GLP Guidance Documents Instructions for Use 1. First, please complete the table below giving the full name of

More information

CHAPTER 5 INFORMATION TECHNOLOGY SERVICES CONTROLS

CHAPTER 5 INFORMATION TECHNOLOGY SERVICES CONTROLS 5-1 CHAPTER 5 INFORMATION TECHNOLOGY SERVICES CONTROLS INTRODUCTION In accordance with Statements on Auditing Standards Numbers 78 and 94, issued by the American Institute of Certified Public Accountants

More information

Outsourcing - managing risks and opportunities over which you now have less control

Outsourcing - managing risks and opportunities over which you now have less control Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance

More information

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (08) 69 R7 VALIDATION OF COMPUTERISED SYSTEMS CORE DOCUMENT Full document title and reference Document type Validation of Computerised

More information

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) GMP Requirements Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) 2016. ALL RIGHTS RESERVED. Outline GMP Procedures and standards

More information

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA

Implement Effective Computer System Validation. Noelia Ortiz, MME, CSSGB, CQA Implement Effective Computer System Validation Noelia Ortiz, MME, CSSGB, CQA Session Outline 1 2 3 4 5 Understanding Regulations and Guidelines Pertaining to Computer Systems Integrate SDLC and GAMP 5

More information

PAI Inspections, Observations and Data Integrity

PAI Inspections, Observations and Data Integrity PAI Inspections, Observations and Data Integrity Krishna Ghosh, Ph.D. Office of Pharmaceutical Quality Office of Process and Facilities Center for Drug Evaluation and Research November, 2017 20 November

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, 6 February 2014 SANCO/TSE/ The received contributions together with the identity of

More information

The Role of the LMS in 21 CFR Part 11 Compliance

The Role of the LMS in 21 CFR Part 11 Compliance The Role of the LMS in 21 CFR Part 11 Compliance Co-author: Dr. Bob McDowall, Director R.D. McDowall Limited ABSTRACT The purpose of this white paper is to describe how NetDimensions Learning addresses

More information

Inspection Hot Topics

Inspection Hot Topics Inspection Hot Topics QP Forum, Trinity College Ciara Turley, Inspector, HPRA 16 th April 2015 Content Hot topics = common deficiencies Data based on 100 inspections conducted in 2014 Inspections of non-sterile

More information

Materials Management Traceability, CEPs and managing non-conforming sites

Materials Management Traceability, CEPs and managing non-conforming sites Materials Management Traceability, CEPs and managing non-conforming sites IMB Information Day, 14 th October 2010 Dr Cormac Dalton Inspector 13-Oct-10 Slide 1 Managing Supply Supply Demand Supply chain

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Medicinal Product quality, safety and efficacy Brussels, 16 August 2013 EudraLex The Rules Governing Medicinal

More information

Software Quality Regulatory Trends

Software Quality Regulatory Trends Software Quality Regulatory Trends By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Software Quality Regulatory

More information

Laboratory Data Integrity Issues Found in Audits and Inspections

Laboratory Data Integrity Issues Found in Audits and Inspections Laboratory Data Integrity Issues Found in Audits and Inspections Presented by: Chris Wubbolt, BS, MS IVT Laboratory Data Integrity December 12 14, 2016 www.qacvconsulting.com 1 Objectives Brief Overview

More information

Risk Assessment is a vital component in

Risk Assessment is a vital component in This article demonstrates how the risk analysis guidance in GAMP 4 can be applied to GMPs and Good Distribution Practices (GDPs). Reprinted from The Official Journal of ISPE PHARMACEUTICAL ENGINEERING

More information

Safeguarding public health. Deficiency Database Figures April June 2009

Safeguarding public health. Deficiency Database Figures April June 2009 Deficiency Database Figures April June 9 Relevant Inspections Performed = Number of Critical Observations = 1 Number of Major Observations = 191 Slide Batch Release Complaint and Product Recall Sterility

More information

Data Integrity Compliance Project

Data Integrity Compliance Project Data Integrity Compliance Project RISK FACTORS FOR DI ISSUES Outsourcing Supply Chain Data Review Practices Increasing use of electronic systems Economic Stressors 2 Fully Integrated into QMS DATA INTEGRITY

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working

More information

Overview of Regulatory Requirements for API and Formulations

Overview of Regulatory Requirements for API and Formulations Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed

More information

Latino America Consultores Innovation & Technology to make your Business Compliant

Latino America Consultores Innovation & Technology to make your Business Compliant Latino America Consultores Innovation & Technology to make your Business Compliant Annex 15 & EMA Process Validation Guide Line 1 Changes in Requirements The Pharmaceutical Industry has adapted its business

More information

ALCOA AND DATA INTEGRITY: PASTAND FUTURE

ALCOA AND DATA INTEGRITY: PASTAND FUTURE ALCOA AND DATA INTEGRITY: PASTAND FUTURE Marina Figini, PCA S.p.A./Aschimfarma Data Integrity: reliability, quality and competitiveness factors of API manufacturers Pavia, 10 Novembre 2017 Good data management

More information

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando GLP Computerized Systems Updates from OECD Guidance Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando 1 Validation EPA GLP Obligation Expectations of the EPA for Computers in GLP (40 CFR

More information

Regulations and guidance for the pharmaceutical industry

Regulations and guidance for the pharmaceutical industry w w w. spec troscopyonline. com April 2011 Spectroscopy 26(4) 1 Focus on Quality Is GMP Annex 11 Europe s Answer to 21 CFR 11? January 2011 saw the publication of the new revision of European Union (EU)

More information

Service Operation. Scenario One

Service Operation. Scenario One Service Operation Scenario One A large corporation completed implementing a new IT service management framework last month and has selected its new service management tools. The new processes of the framework

More information

Self-Inspection and its potential benefits via ICH Q9 & Q10

Self-Inspection and its potential benefits via ICH Q9 & Q10 Self-Inspection and its potential benefits via ICH Q9 & Q10 Kevin O Donnell, Ph.D. Senior Inspector & Market Compliance Manager Irish Medicines Board IMB Information Day October 23 rd, 2008 Slide 1 Topics

More information

ISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues

ISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues Detecting GMP Data Integrity Issues Elaine Eborall Senior Director, GMP Compliance, Americas and Asia Pacific Compliance and External Collaboration ISPE-FDA cgmp Conference Baltimore, Maryland 2-4 June

More information

GOVERNANCE AES 2012 INFORMATION TECHNOLOGY GENERAL COMPUTING CONTROLS (ITGC) CATALOG. Aut. / Man. Control ID # Key SOX Control. Prev. / Det.

GOVERNANCE AES 2012 INFORMATION TECHNOLOGY GENERAL COMPUTING CONTROLS (ITGC) CATALOG. Aut. / Man. Control ID # Key SOX Control. Prev. / Det. GOVERNANCE 8.A.1 - Objective: Information Technology strategies, plans, personnel and budgets are consistent with AES' business and strategic requirements and goals. Objective Risk Statement(s): - IT Projects,

More information

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE 1. PURPOSE The purpose of this SOP is to define the minimum requirements for Computer Systems Validation (CSV) at (insert name of company

More information

Guidance for Industry - Computerized Systems Used in Clinical Trials

Guidance for Industry - Computerized Systems Used in Clinical Trials Page 1 of 14 Regulatory Information Computerized Systems Used in Clinical Trials Guidance for Industry - Computerized Systems Used in Clinical Trials

More information

10 "Must-Haves" for the Life Sciences Learning Management System

10 Must-Haves for the Life Sciences Learning Management System 10 "Must-Haves" for the Life Sciences Learning Management System Why the Life Sciences LMS Needs to Demonstrate Record Control UL talks to many Life Sciences companies that are exploring learning and development

More information

Service Operation. Scenario One

Service Operation. Scenario One Service Operation Scenario One A large corporation completed implementing a new IT service management framework last month and has selected its new service management tools. The new processes of the framework

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

A Comprehensive Approach to Find and Remediate Data Integrity Problems

A Comprehensive Approach to Find and Remediate Data Integrity Problems A Comprehensive Approach to Find and Remediate Data Integrity Problems June 14, 2017 Copyright 2017 QuintilesIMS. All rights reserved. What is data integrity? Whom does it apply to? Definitions matter

More information

GxP Compliance for Computerized Systems

GxP Compliance for Computerized Systems GxP Compliance for Computerized Systems The Second Annual Pharmaceutical Industry Regulatory and Compliance Summit David L. Stone General Manager, Validation Services Glemser Technologies June 13, 2001

More information

FLORIDA DEPARTMENT OF TRANSPORTATION

FLORIDA DEPARTMENT OF TRANSPORTATION FLORIDA DEPARTMENT OF TRANSPORTATION 6-month Follow-up to the Office of the Auditor General Information Technology Operational Audit-Department of Transportation Electronic Estimate Disbursement System

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Aarti Drugs Limited

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements

More information

Installation Qualification Equipment (Reference SOP: )

Installation Qualification Equipment (Reference SOP: ) Installation Qualification Equipment (Reference SOP: ) Project: Equipment Description: Project No: Serial No: Manufacturer: Model No: Equipment No: Location: Protocol: PROGRAM INDEX 1. OBJECTIVE...3 2.

More information

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009 European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities

More information

No. Question Answer IT Qualification Statement 1 SITE CONTACT

No. Question Answer IT Qualification Statement 1 SITE CONTACT SITE: Alfred Health Clinical Information System Summary of Key Questions in regards to Electronic Medical Records and Clinical Trials 1 SITE CONTACT 1.1 Name of Systems Administrator/ Security Contact/

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines

More information

Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM

Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory

More information